At a glance
ClinicalIndex Comparison RecordN/ACompleted· 197 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Allofit® IT With HXPE in Total Hip Arthroplasty. A Multi-center, Prospective, Non-controlled Post Market Surveillance Study
In Brief
An observational study for Avascular Necrosis and 3 related conditions. Completed, enrolled 197 participants across 5 sites in 4 countries.
Detailed Summary
The study design is a multi-center, prospective, non-controlled, consecutive cohort postmarket clinical follow-up study to obtain survival and outcome data on the Allofit IT Shell in combination with Longevity Liners in primary total hip arthroplasty.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAvascular Necrosis, Osteoarthritis, Hip, Inflammatory Arthritis, Post-Traumatic Osteoarthritis of Hip
CountriesAustria, France, Germany, Spain
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedSep 2018
Primary CompletionJul 2025
TodayJul 2026
First PostedSep 17, 2018
Enrollment StartJun 5, 2011
Primary CompletionJul 3, 2025
TodayJul 2, 2026
Enrollment to primary: 14.1 yearsPosted 7.8 years ago